Published Health Economics Study shows Improved Treatment for Female Urinary Incontinence may have Positive Effect on Patient Outcomes and Healthcare Costs June 22, 2022
Carbon Biosciences Emerges with a New Viral Vector to Shake up the Cystic Fibrosis Gene Therapy Field June 21, 2022
Carbon Biosciences Launches with $38 Million Series A Financing to Advance Novel Gene Therapy Platform and Pipeline June 21, 2022
Lassen Therapeutics Presents New Preclinical Data on IL-11 Receptor-blocking as a Novel Therapeutic Approach for Skin Fibrosis June 16, 2022
Be Bio and Resilience Announce Strategic Collaboration to Manufacture Engineered B Cells, a New Class of Cellular Medicines June 7, 2022
